An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
The United States and Jordan have carried out a major military operation in Syria called…
Jammu & Kashmir has achieved an important milestone in the modernization of public services with…
At the 2ndWHO Global Summit on Traditional Medicine held in New Delhi, Narendra Modi released…
Prime Minister Narendra Modi to inaugurate the new terminal building of Lokpriya Gopinath Bordoloi International…
Birds are one of the most fascinating creatures on Earth. They can fly high in…
Veteran Malayalam actor, writer, and director Sreenivasan has passed away at 69. Known for sharp…